ASN Neuro

SJR Rank #3,063H-index: 62SJR: 1.322Best quartile: Q1Open AccessAPC: US$1,950Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

SAGE Publications Inc.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • Neurology (clinical)Q1
  • Neuroscience (miscellaneous)Q1

Areas: Medicine · Neuroscience

Most published research topics

Neuroinflammation and Neurodegeneration MechanismsNeurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology ResearchNerve injury and regenerationAlzheimer's disease research and treatmentsMitochondrial Function and PathologyParkinson's Disease Mechanisms and TreatmentsRNA regulation and diseaseMicroRNA in disease regulationRNA Research and Splicing

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs020406080

Documents per Year

2022202509182736

Detailed Information

ISSN

1759-0914

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.48

References per Document

46.86

Coverage

2009-2026

Scope

ASN NEURO is an open access, peer-reviewed journal uniquely positioned to provide investigators with the most recent advances across the breadth of the cellular and molecular neurosciences. The official journal of the American Society for Neurochemistry, ASN NEURO is dedicated to the promotion, support, and facilitation of communication among cellular and molecular neuroscientists of all specializations. The open access platform and comprehensive scope of the journal allow for rapid dissemination of current research across disciplines to contribute to a complete approach to issues pertaining to the nervous system. High-quality research articles and reviews in such areas as neurochemistry and biology, neurogenetics, glial cells and function, neurodevelopment, neurodegeneration and repair, neuroimmunity, signaling, and other neuro- or glial-related topics are encouraged for submission.

Metrics from SCImago Journal Rank 2025. View on SCImago